OWD
ELV icon

Osborn Williams & Donohoe’s Elevance Health ELV Stock Holding History

Osborn Williams & Donohoe’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$562K Sell
2,474
-79
-3% -$21.5K 0.07% 177
2019
Q4 		$771K Sell
2,553
-24
-0.9% -$6.6K 0.08% 191
2019
Q3 		$619K Buy
2,577
+1
+0% +$274 0.06% 206
2019
Q2 		$727K Sell
2,576
-1,287
-33% -$352K 0.07% 192
2019
Q1 		$1.07M Sell
3,863
-46
-1% -$13.3K 0.11% 173
2018
Q4 		$1.03M Buy
3,909
+2
+0.1% +$550 0.18% 114
2018
Q3 		$1.07M Sell
3,907
-48
-1% -$12.5K 0.17% 116
2018
Q2 		$941K Buy
3,955
+2
+0.1% +$463 0.16% 120
2018
Q1 		$868K Sell
3,953
-22
-0.6% -$5.17K 0.15% 123
2017
Q4 		$895K Buy
3,975
+2
+0.1% +$426 0.15% 116
2017
Q3 		$754K Sell
3,973
-698
-15% -$133K 0.14% 125
2017
Q2 		$879K Sell
4,671
-68
-1% -$12.2K 0.16% 118
2017
Q1 		$784K Sell
4,739
-22
-0.5% -$3.5K 0.14% 125
2016
Q4 		$684K Sell
4,761
-400
-8% -$53.6K 0.13% 129
2016
Q3 		$647K Sell
5,161
-133
-3% -$17.2K 0.12% 139
2016
Q2 		$695K Buy
5,294
+366
+7% +$50.1K 0.14% 125
2016
Q1 		$685K Sell
4,928
-800
-14% -$107K 0.14% 126
2015
Q4 		$799K Hold
5,728
– – 0.16% 116
2015
Q3 		$813K Sell
5,728
-100
-2% -$15K 0.18% 110
2015
Q2 		$879K Sell
5,828
-650
-10% -$104K 0.18% 112
2015
Q1 		$1M Sell
6,478
-775
-11% -$110K 0.19% 107
2014
Q4 		$911K Sell
7,253
-650
-8% -$80.3K 0.18% 104
2014
Q3 		$945K Sell
7,903
-25
-0.3% -$2.87K 0.2% 105
2014
Q2 		$879K Sell
7,928
-200
-2% -$20.6K 0.18% 105
2014
Q1 		$809K Hold
8,128
– – 0.18% 108
2013
Q4 		$751K Sell
8,128
-50
-0.6% -$4.44K 0.17% 115
2013
Q3 		$684K Sell
8,178
-200
-2% -$17.1K 0.17% 114
2013
Q2 		$686K Buy
+8,378
New +$627K 0.18% 108

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osborn Williams & Donohoe's ELV Position: Q1 2020 in Review

Osborn Williams & Donohoe reduced its Elevance Health (ELV) stake by 3.1% in Q1 2020, selling an estimated $21.5K and leaving 2,474 shares worth $562K. The position accounts for 0.07% of the portfolio, ranked #177.

Osborn Williams & Donohoe first reported a position in ELV in Q2 2013 and has held it in 28 quarters since. The position peaked at $1.07M in Q3 2018. 1,051 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Osborn Williams & Donohoe held 2,474 shares of Elevance Health worth $562K as of Q1 2020.
  • Osborn Williams & Donohoe sold 79 Elevance Health shares in Q1 2020, an estimated $21.5K.
  • Elevance Health made up 0.07% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #177 holding.
  • Osborn Williams & Donohoe first reported a position in Elevance Health in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's Elevance Health position peaked at $1.07M in Q3 2018.
  • 1,051 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.